ISSN 1612-3352

Editors in Chief

Prof. Dr. Claus F. Claussen, Neurootological Research Institute of the Research Society for Smell, Taste, Hearing and Equilibrium Disorders at Bad Kissingen (4-G-F). Bad Kissingen, Germany.
Dr. med. Julia M. Bergmann,
Dr. med. Guillermo O. Bertora,
Otoneuroophthalmological Neurophysiology,
Buenos Aires, Argentina.

Production Managers

Dr. med. Julia M. Bergmann,
Dr. med. Guillermo O. Bertora,
Otoneuroophthalmological Neurophysiology,
Buenos Aires, Argentina.

Associated Editors

The editors welcome authors to submit articles for publications in the ASN.

Read the Information for Authors.

Kurhausstraße 12
D-97688 Bad Kissingen
Telefon +49-971-6 4832
Fax +49- 971- 6 8637


Archive by date

Year 2010

Types of dizziness, evidence-based approach

Dizziness affects about 20 % of general population and more then 30 % of patients. Thus, being important the problem has descriptive manner of approach and no even exact identification. Therefore, the problem of this presentation is identification of types of dizziness with instrumental investigation methods. The data of 849 patients has been examined with […]

Vestibular disorders in childhood and adolescents

The aim of this study to analyze the data of 145 vertiginous patients aged up to 18 years, which were examined at the Otoneurological Department of the Semmelweis University during the last five years. For the analysis, group of children (aged up to 14 years) and group of adolescents (ages between 14-18 years,) were formed. […]

The assay of the patients in a period of five years at our otoneurological department

The authors aim to process the data of the patients in a period of the last five years at the Otoneurological Department. They have examined the distribution of the patients according to their age and gender. They have also inspected the most common diseases. The number of patients has been assessed in monthly distribution, too. […]

Final Common Pathway for Tinnitus: Theoretical and Clinical Implications of Neuroanatomical Substrates

A final common pathway (FCP) for tinnitus has been hypothesized since 1989 for all clinical types of tinnitus, particularly subjective idiopathic tinnitus (SIT) of the severe disabling type. This was intended to explain the transformation-transition of the sensation of an aberrant auditory sensation—tinnitus (i.e., the sensory component)—to one of affect (i.e., the emotional-behavioral component) or, […]

Central Nervous System Neurodegeneration and Tinnitus: A Clinical Experience Part II: Translational Neurovascular Theory of Neurodegenerative CNS Disease and Tinnitus

The translation of a neurovascular hypothesis for Alzheimer’s disease to subjective idiopathic tinnitus (SIT) is presented as a challenge to the predominantly sensorineural view of SIT and its clinical application for tinnitus treatment. The concept of neurovascular dysfunction and neurodegeneration (ND) in SIT patients has been proposed and reported as an etiology in a particular […]

Central Nervous System Neurodegeneration and Tinnitus: A Clinical Experience Part I: Diagnosis

CNS Neurodegeneration and Tinnitus IIn an evolving clinical experience since 1979, the medical significance of the symptom of tinnitus has been identified as a “soft” sign of neurodegeneration (ND) in the central nervous system (CNS) in a particular subset of tinnitus patients diagnosed with a predominantly central-type, severe, disabling, subjective idiopathic tinnitus.To highlight this experience, […]

Hygroma. Report, a Case

Cystic hygroma was first described in 1828 and referred to as a “moist tumor.Today, this benign developmental tumor is recognized as a lymphatic malformation (also known as a lymphangioma).Cystic hygroma is a benign lymphatic malformation representing 5% to 6% of all benign tumors and 1% of all tumors (benign and malignant). Most (90%) cystic hygromas […]

Tinnitus: A New Model of Pharmacological Therapy

Tinnitus Therapy schedule developed by us, we based on the schema of the auditory via and on the cortico -striatum- thalamus -cortical control system. The selected medicine or neurotransmitter will be directed to regulating the neuronal hyperactivity or hypoactivity functions, depending on the topographical location of tinnitus. It is impossible to treat tinnitus by a […]



If you are not already registered, please register here for free.

If you are registered but have forgotten your password (or you never had one), click here to recover your password.

Proceedings of



2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 |